Hover over the dot(s) for more information
We do not provide kits or instructions for unsupervised self-injection
Catalina then uses this profile to personalize messaging and develop an integrated activation strategy across online and offline channels
I have to listen to my body for other cues that I need to eat, because I can quite happily go out, have a full active day, and not feel the need to eat at all. (P1, male, obesity)
Is retatrutide (LY3437943), a GLP-1, GIP, and glucagon receptor agonist a step forward in the treatment of diabetes and obesity
Alison Cave, the MHRAs Chief Safety Officer, emphasized the importance of informed decision-making: The decision to start, continue, or stop treatments should be made jointly by patients and their doctor, based on full consideration of benefits and risks. This statement underscores a key point: while the numbers are concerning, they must be contextualized within the millions of prescriptions issued and the complex health profiles of the patients taking these drugs
